Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.

Wang H, Zhang X, Wang L, Zheng G, Du L, Yang Y, Dong Z, Liu Y, Qu A, Wang C.

J Surg Oncol. 2014 May;109(6):574-9. doi: 10.1002/jso.23526. Epub 2013 Dec 11.

PMID:
24338523
2.

Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.

Shen C, Hu L, Xia L, Li Y.

Jpn J Clin Oncol. 2008 Nov;38(11):770-6. doi: 10.1093/jjco/hyn105. Epub 2008 Oct 8.

PMID:
18845519
3.

The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.

Wu P, Tang RN, Zou JH, Wang FC.

Hepatogastroenterology. 2012 Oct;59(119):2164-7. doi: 10.5754/hge12539.

PMID:
23178553
4.

Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients.

Wang W, Li Y, Zhang X, Jing J, Zhao X, Wang Y, Han C.

J Surg Oncol. 2014 Apr;109(5):440-4.

PMID:
24783267
5.

Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.

Ferroni P, Roselli M, Spila A, D'Alessandro R, Portarena I, Mariotti S, Palmirotta R, Buonomo O, Petrella G, Guadagni F.

Cancer. 2010 Jun 15;116(12):2913-21. doi: 10.1002/cncr.25094.

6.

Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.

Wang T, Qian X, Wang Z, Wang L, Yu L, Ding Y, Liu B.

Int J Cancer. 2009 Oct 15;125(8):1921-5. doi: 10.1002/ijc.24516.

7.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

9.

Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.

Gao JY, Song BR, Peng JJ, Lu YM.

World J Gastroenterol. 2012 Nov 7;18(41):5965-71. doi: 10.3748/wjg.v18.i41.5965.

10.

SALL4 as a new biomarker for early colorectal cancers.

Ardalan Khales S, Abbaszadegan MR, Abdollahi A, Raeisossadati R, Tousi MF, Forghanifard MM.

J Cancer Res Clin Oncol. 2015 Feb;141(2):229-35. doi: 10.1007/s00432-014-1808-y. Epub 2014 Aug 26.

PMID:
25156818
11.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
12.

Direct serum assay for cell-free bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer.

Zhang X, Yang X, Zhang Y, Liu X, Zheng G, Yang Y, Wang L, Du L, Wang C.

Clin Cancer Res. 2015 Mar 1;21(5):1225-33. doi: 10.1158/1078-0432.CCR-14-1761. Epub 2014 Dec 29.

13.

Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.

Sadahiro S, Suzuki T, Maeda Y, Yurimoto S, Yasuda S, Makuuchi H, Kamijo A, Murayama C.

Ann Surg Oncol. 2007 Mar;14(3):1092-8. Epub 2007 Jan 3.

PMID:
17200912
14.

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Gaber A, Nodin B, Hotakainen K, Nilsson E, Stenman UH, Bjartell A, Birgisson H, Jirström K.

BMC Cancer. 2010 Sep 17;10:498. doi: 10.1186/1471-2407-10-498.

15.
16.

Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.

Iinuma H, Okinaga K, Egami H, Mimori K, Hayashi N, Nishida K, Adachi M, Mori M, Sasako M.

Int J Oncol. 2006 Feb;28(2):297-306.

PMID:
16391782
17.

Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.

Ohlsson L, Israelsson A, Öberg Å, Palmqvist R, Stenlund H, Hammarström ML, Hammarström S, Lindmark G.

Int J Cancer. 2012 Apr 15;130(8):1833-43. doi: 10.1002/ijc.26182. Epub 2011 Aug 16.

18.

Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.

Ding W, Wang J, Wang F, Wang G, Wu Q, Ju S, Cong H, Wang H.

Clin Biochem. 2013 Oct;46(15):1590-4. doi: 10.1016/j.clinbiochem.2013.06.008. Epub 2013 Jun 18.

PMID:
23792260
19.

Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.

Kim MJ, Lim KY, Kim JW, Nam IW, Lee JH, Myoung H.

Cancer Lett. 2005 Jun 28;224(2):253-61.

PMID:
15914276
20.

Prognostic implications of serum microRNA-21 in colorectal cancer.

Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415. Epub 2013 Aug 23.

PMID:
23970420

Supplemental Content

Support Center